Clinical Trial Update: Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the long-term effect of dupilumab on preventing lung function decline in adults with uncontrolled moderate-to-severe asthma;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Sanofi | Conditions: Asthma | Phase 4 | Status: ACTIVE_NOT_RECRUITING